Primary retroperitoneal lymph node dissection for clinical stage II seminoma: A systematic review and meta-analysis of safety and oncological effectiveness-Reference-Cited by-同舟云学术

Primary retroperitoneal lymph node dissection for clinical stage II seminoma: A systematic review and meta-analysis of safety and oncological effectiveness

Published:2024-04 Issue:4 Volume:42 Page:102-109
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Kardoust Parizi Mehdi^ORCID,Margulis Vitaly,Bagrodia Aditya,Bekku Kensuke,Klemm Jakob,Matsukawa Akihiro,Alimohammadi Arman,Motlagh Reza Sari,Mostafaei Hadi,Laukhtina Ekaterina,Shariat Shahrokh F.

Publisher

Elsevier BV

Reference28 articles.

1. Recent global trends in testicular cancer incidence and mortality;Park;Medicine (United States),2018

2. Stage II testicular seminoma: patterns of recurrence and outcome of treatment;Chung;Eur Urol,2004

3. Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes;Giannatempo;Ann Oncol,2015

4. Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era;Hellesnes;Int J Cancer,2020

5. Comparative effectiveness of surveillance, primary chemotherapy, radiotherapy and retroperitoneal lymph node dissection for the management of early stage testicular germ cell tumors: a systematic review;Pierorazio;J Urol,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II A/B Seminomas: A Systematic Review and Meta-Analysis;International braz j urol;2024-08